See more : Aspinwall and Company Limited (ASPINWALL.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Maywufa Company Ltd. (1731.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Maywufa Company Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Medeon Biodesign, Inc. (6499.TWO) Income Statement Analysis – Financial Results
- IRIS Business Services Limited (IRIS.BO) Income Statement Analysis – Financial Results
- Gokul Agro Resources Limited (GOKULAGRO.NS) Income Statement Analysis – Financial Results
- Skyfame Realty (Holdings) Limited (0059.HK) Income Statement Analysis – Financial Results
- ZST Digital Networks, Inc. (ZSTN) Income Statement Analysis – Financial Results
Maywufa Company Ltd. (1731.TW)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.maywufa.com.tw
About Maywufa Company Ltd.
Maywufa Company Ltd. manufactures and sells hair and skin care products under the Maywufa brand in Taiwan. It offers hair care products; health care products and food supplements; and mother and baby skin care products under the mustela brand. The company also provides pharmaceuticals and medical devices, such as PG2 Lyophilized injection for treatment of cancer-related fatigue; AmCad-UT Detection device, an ultrasound CAD for thyroid cancer detection; Bio-Three tablets for the treatment of mild diarrhea, abdominal pain, and constipation; and Cerebrolysin, a supplementary nutrient boost for patients who cannot ingest adequate food and patients who have difficulties in the digestion, absorption, synthesis, and utilization of proteins, as well as for patients suffering from severe trauma, burns, fractures, insufficient protein intake, or malnutrition. In addition, it sells and distributes pharmaceutical products; and operates and manages pharmacy chain under the Pharmacy Franchise name. Maywufa Company Ltd. was founded in 1976 and is headquartered in Taipei, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.30B | 1.25B | 1.29B | 1.07B | 1.10B | 1.12B | 1.58B | 1.44B | 1.37B | 1.23B | 1.51B | 2.15B | 2.25B | 3.01B | 2.86B |
| Cost of Revenue | 446.35M | 428.55M | 429.77M | 389.05M | 430.98M | 479.03M | 897.99M | 822.89M | 738.65M | 669.15M | 982.51M | 1.59B | 1.69B | 2.36B | 2.22B |
| Gross Profit | 854.37M | 816.56M | 859.44M | 676.27M | 669.88M | 644.37M | 677.09M | 620.18M | 630.54M | 563.72M | 529.82M | 552.15M | 555.99M | 644.99M | 638.00M |
| Gross Profit Ratio | 65.68% | 65.58% | 66.66% | 63.48% | 60.85% | 57.36% | 42.99% | 42.98% | 46.05% | 45.72% | 35.03% | 25.72% | 24.74% | 21.43% | 22.32% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 103.86M | 98.45M | 101.44M | 103.61M | 105.62M | 110.17M | 116.93M | 117.42M | 124.05M | 126.49M | 106.51M | 91.34M | 78.61M | 94.78M | 69.82M |
| Selling & Marketing | 555.17M | 519.60M | 541.11M | 402.08M | 410.64M | 396.88M | 401.20M | 375.25M | 393.91M | 362.48M | 352.23M | 397.14M | 453.71M | 518.27M | 555.36M |
| SG&A | 659.03M | 618.05M | 642.55M | 505.69M | 516.26M | 507.04M | 518.12M | 492.66M | 517.96M | 488.98M | 458.74M | 488.48M | 532.31M | 613.05M | 625.18M |
| Other Expenses | 0.00 | 24.06M | 17.71M | 242.00K | 5.70M | 6.70M | 7.54M | 8.36M | 9.51M | 7.02M | 6.22M | 25.40M | 30.26M | 25.05M | 8.41M |
| Operating Expenses | 659.70M | 618.05M | 660.26M | 505.93M | 521.95M | 506.80M | 518.10M | 492.70M | 517.49M | 487.57M | 454.26M | 488.48M | 532.31M | 613.05M | 625.18M |
| Cost & Expenses | 1.11B | 1.05B | 1.09B | 894.99M | 952.94M | 985.83M | 1.42B | 1.32B | 1.26B | 1.16B | 1.44B | 2.08B | 2.22B | 2.98B | 2.85B |
| Interest Income | 7.60M | 5.40M | 4.89M | 5.25M | 4.46M | 3.97M | 1.99M | 1.98M | 4.73M | 2.99M | 3.25M | 2.88M | 2.14M | 615.00K | 456.00K |
| Interest Expense | 92.00K | 2.56M | 5.31M | 5.13M | 5.34M | 4.96M | 4.16M | 4.33M | 4.36M | 5.71M | 6.44M | 6.44M | 6.53M | 7.15M | 6.19M |
| Depreciation & Amortization | 28.80M | 29.28M | 31.03M | 33.99M | 39.46M | 30.53M | 31.14M | 31.51M | 34.43M | 35.22M | 29.84M | 27.24M | 21.71M | 15.45M | 16.02M |
| EBITDA | 239.14M | 239.54M | 268.51M | 268.02M | 217.89M | 185.80M | 193.15M | 183.69M | 133.55M | 182.29M | 105.45M | 80.40M | 117.84M | 39.75M | 117.32M |
| EBITDA Ratio | 18.38% | 19.24% | 19.20% | 20.03% | 16.30% | 13.04% | 10.34% | 9.93% | 9.75% | 12.60% | 7.02% | 4.76% | 2.28% | 1.32% | -0.15% |
| Operating Income | 195.35M | 210.26M | 216.45M | 179.42M | 140.00M | 137.57M | 158.99M | 127.48M | 113.06M | 76.15M | 75.56M | 63.67M | 23.67M | 31.94M | 12.82M |
| Operating Income Ratio | 15.02% | 16.89% | 16.79% | 16.84% | 12.72% | 12.25% | 10.09% | 8.83% | 8.26% | 6.18% | 5.00% | 2.97% | 1.05% | 1.06% | 0.45% |
| Total Other Income/Expenses | 14.90M | -1.91M | -4.66M | 37.32M | -13.10M | -26.38M | -44.09M | -20.01M | -18.30M | 19.61M | -5.68M | -13.46M | 65.93M | 96.95M | 82.29M |
| Income Before Tax | 210.25M | 208.35M | 211.78M | 207.65M | 134.83M | 111.19M | 114.90M | 107.47M | 94.76M | 95.75M | 69.88M | 63.26M | 61.77M | 91.61M | 95.11M |
| Income Before Tax Ratio | 16.16% | 16.73% | 16.43% | 19.49% | 12.25% | 9.90% | 7.30% | 7.45% | 6.92% | 7.77% | 4.62% | 2.95% | 2.75% | 3.04% | 3.33% |
| Income Tax Expense | 41.15M | 46.52M | 47.46M | 36.65M | 34.23M | 35.42M | 28.97M | 16.73M | 15.68M | 15.23M | 6.31M | 3.54M | 19.68M | 25.70M | 32.56M |
| Net Income | 169.10M | 161.83M | 164.32M | 171.00M | 100.61M | 75.77M | 85.94M | 90.73M | 79.09M | 80.52M | 63.57M | 59.72M | 42.09M | 58.11M | 57.63M |
| Net Income Ratio | 13.00% | 13.00% | 12.75% | 16.05% | 9.14% | 6.74% | 5.46% | 6.29% | 5.78% | 6.53% | 4.20% | 2.78% | 1.87% | 1.93% | 2.02% |
| EPS | 1.27 | 1.22 | 1.24 | 1.29 | 0.76 | 0.57 | 0.65 | 0.68 | 0.60 | 0.61 | 0.48 | 0.34 | 0.32 | 0.45 | 0.50 |
| EPS Diluted | 1.27 | 1.22 | 1.23 | 1.28 | 0.75 | 0.57 | 0.65 | 0.68 | 0.59 | 0.60 | 0.48 | 0.34 | 0.32 | 0.44 | 0.49 |
| Weighted Avg Shares Out | 133.15M | 132.91M | 132.92M | 132.92M | 132.92M | 132.92M | 132.92M | 132.92M | 132.92M | 132.92M | 132.92M | 132.53M | 131.15M | 130.44M | 115.38M |
| Weighted Avg Shares Out (Dil) | 133.27M | 132.92M | 133.32M | 133.40M | 133.29M | 133.29M | 133.22M | 133.25M | 133.17M | 133.31M | 133.10M | 132.69M | 131.54M | 131.42M | 117.77M |
Source: https://incomestatements.info
Category: Stock Reports